Monday, February 8, 2010

Migraine Home>
News>
Clinical trial: Trexima vs. BCM meds for acute migraine

Font size
- A
- A
- A
Email This

Bookmark

Save

Clinical trial: Trexima vs. BCM meds for acute migraine

(National Institutes of Health) UPDATED 2008-03-06

This is a study to compare the effects of Trexima to butalbital-containing combination medications (BCM) for the acute treatment of migraine headaches. This national study is currently recruiting adults ages 18 years to 65 years who suffer from migraines and who already use BCM meds. Read full story >

See all Migraine News

Related: acetaminophen, Treximet

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2010. The HealthCentral Network, Inc. All rights reserved.